Tailored therapy and bloodless supportive care measures for a Jehovah’s witness with metastatic Ewing sarcoma

A seventeen-year-old Jehovah’s witness with metastatic Ewing sarcoma initially declined cancer therapy due to the risk of life-threatening bone marrow suppression. He then subsequently agreed to other treatment options with bloodless supportive care measures in order to achieve quality of life and long-term control of his disease. This case report adds to the collective knowledge of providing treatment options including bloodless supportive care measures for Jehovah’s witness patients with cancer.